[Answered] The most contentious part of most IT projects is the costs and benefits. Indicate whether the ...

This topic contains a solution. Click here to go to the answer

Author Question: The most contentious part of most IT projects is the costs and benefits. Indicate whether the ... (Read 46 times)

Hungry!

Hero Member
Posts: 1,071

on: Jul 7, 2018

The most contentious part of most IT projects is the costs and benefits.

Indicate whether the statement is true or false

Question 2

To protect against message sniffing, messages should be:

A)

backed up.
B)

nonrepudiated.
C)

encrypted.
D)

All of the above

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

morrie123456

Sr. Member
Posts: 314

Reply #1 on: Jul 7, 2018

Answer to Question 1

TRUE

Answer to Question 2

C

Hungry!

Member
Posts: 1,071

Reply 2 on: Jul 7, 2018

YES! Correct, THANKS for helping me on my review

ryansturges

Member
Posts: 338

Reply 3 on: Yesterday

TYSM

« previous next »

Did you know?

Pope Sylvester II tried to introduce Arabic numbers into Europe between the years 999 and 1003, but their use did not catch on for a few more centuries, and Roman numerals continued to be the primary number system.

Did you know?

Adult head lice are gray, about ? inch long, and often have a tiny dot on their backs. A female can lay between 50 and 150 eggs within the several weeks that she is alive. They feed on human blood.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.